BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3
53109 results:

  • 1. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
    Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
    Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
    Aung TM; Ngamjarus C; Proungvitaya T; Saengboonmee C; Proungvitaya S
    PLoS One; 2024; 19(5):e0303337. PubMed ID: 38758750
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
    Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
    Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
    Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
    Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
    Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
    Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Preoperative walking exercise to improve prognosis in patients with supratentorial brain tumours after craniotomy: protocol for a randomised controlled trial.
    Qu C; Cao Z; Zhou J; He S; Liu F; Liu Z
    BMJ Open; 2024 May; 14(5):e080787. PubMed ID: 38754891
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study.
    Zheng Y; Chen Z; Song W; Xu Y; Zhao Z; Sun Y; Wang Y; Geng X; Zhao J; Zhang X; Xu Y; Chan JSK; Tse G; Li G; Hong L; Liu T
    Cancer Med; 2024 May; 13(10):e7233. PubMed ID: 38752474
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnosis rates, therapeutic characteristics, lifestyle, and cancer screening habits of patients with diabetes mellitus in a highly deprived region in Hungary: a cross-sectional analysis.
    Pártos K; Major D; Dósa N; Fazekas-Pongor V; Tabak AG; Ungvári Z; Horváth I; Barta I; Pozsgai É; Bodnár T; Fehér G; Lenkey Z; Fekete M; Springó Z
    Front Endocrinol (Lausanne); 2024; 15():1299148. PubMed ID: 38752177
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Dysregulation of platelet serotonin, 14-3-3, and GPIX in sudden infant death syndrome.
    Frelinger AL; Haynes RL; Goldstein RD; Berny-Lang MA; Gerrits AJ; Riehs M; Haas EA; Paunovic B; Mena OJ; Campman SC; Milne GL; Sleeper LA; Kinney HC; Michelson AD
    Sci Rep; 2024 May; 14(1):11092. PubMed ID: 38750089
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MAPP unravels frequent co-regulation of splicing and polyadenylation by RNA-binding proteins and their dysregulation in cancer.
    Bak M; van Nimwegen E; Kouzel IU; Gur T; Schmidt R; Zavolan M; Gruber AJ
    Nat Commun; 2024 May; 15(1):4110. PubMed ID: 38750024
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. METTL8 links mt-tRNA m
    Lee BWL; Chuah YH; Yoon J; Grinchuk OV; Liang Y; Hirpara JL; Shen Y; Wang LC; Lim YT; Zhao T; Sobota RM; Yeo TT; Wong ALA; Teo K; Nga VDW; Tan BWQ; Suda T; Toh TB; Pervaiz S; Lin Z; Ong DST
    Cell Death Dis; 2024 May; 15(5):338. PubMed ID: 38744809
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Zavegepant for Acute Treatment of Migraine: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Suresh V; Bardhan M; Dave T; Shamim MA; Suresh D; Satish P; Dhakal B; Bhonsale A; Roy P; Padhi BK; Monteith T
    Clin Neuropharmacol; 2024 May-Jun 01; 47(3):72-81. PubMed ID: 38743600
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for Medulloblastoma.
    Ji Q; McAfee SS; Scoggins M; Holtrop J; Glass JO; Yuan X; Liang J; Li Y; Chiang J; Orr BA; Edwards A; Storment D; Brinkman T; Robinson GW; Gajjar A; Reddick WE; Patay Z; Khan RB; Bag AK
    Radiology; 2024 May; 311(2):e232521. PubMed ID: 38742969
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Descriptive epidemiology of 30,223 histopathologically confirmed meningiomas in France: 2006-2015.
    Depond CC; Zouaoui S; Darlix A; Rigau V; Mathieu-Daudé H; Bauchet F; Khettab M; Trétarre B; Figarella-Branger D; Taillandier L; Boetto J; Pallud J; Zemmoura I; Roche PH; Bauchet L; ; ;
    Acta Neurochir (Wien); 2024 May; 166(1):214. PubMed ID: 38740641
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Periorbital Oedema Associated with Hypothyroidism - A Case Report.
    Noaman BR; Bazrgan AM
    Indian J Dent Res; 2023 Oct; 34(4):455-457. PubMed ID: 38739832
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
    da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
    Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France.
    Petit T; Hajjaji N; Antoine EC; Benderra MA; Gozy M; Foa C; Mouysset JL; Grenier J; Mousseau M; Mailliez A; Saghatchian M; Lachaier E; Desmoulins I; Hennequin A; Maes P; Loirat D; Ricci F; Diéras V; Berton D; Tiong FL; Teixeira L; Dohollou N; Lévy C; Bachelot T; Pierga JY
    Cancer Med; 2024 May; 13(9):e7168. PubMed ID: 38733172
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Potential of the Fibronectin Inhibitor arg-Gly-Asp-Ser in the Development of Therapies for Glioblastoma.
    Castro-Ribeiro ML; Castro VIB; Vieira de Castro J; Pires RA; Reis RL; Costa BM; Ferreira H; Neves NM
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732135
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Extraneural metastatic ependymoma: distant metastasis to the pleura, lungs, lymph nodes and bone.
    Guirguis M; Jiang Z; Cai C; Youssef M
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38729658
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Management of Autoimmune Encephalitis in a 7-Year-Old Child With CTLA-4 Haploinsufficiency and AMPA Receptor Antibodies: A Case Report.
    Quaak MSW; Buijze MSJS; Verhoeven VJM; Vermont C; Buddingh EP; Heredia M; Samsom JN; Titulaer MJ; van Rossum AM; Kamphuis S; Neuteboom RF
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200254. PubMed ID: 38728609
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2656.